Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
Oncogene, 2016 - nature.com
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
[PDF][PDF] Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2015 - researchgate.net
Renal cell carcinoma (RCC) is an epithelial tumor derived from the proximal tubules of
nephrons. 1 The major subtype of RCC (~ 75%) is clear cell RCC (ccRCC). 2 Clinically …
nephrons. 1 The major subtype of RCC (~ 75%) is clear cell RCC (ccRCC). 2 Clinically …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang… - …, 2016 - mdanderson.elsevierpure.com
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2016 - go.gale.com
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
[引用][C] Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2015 - cir.nii.ac.jp
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2015 - europepmc.org
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
[HTML][HTML] Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2016 - ncbi.nlm.nih.gov
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2016 - go.gale.com
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
L Zhou, XD Liu, M Sun, X Zhang, P German, S Bai… - Oncogene, 2015 - europepmc.org
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …
carcinoma (RCC). The purpose of this study was to understand the mechanism of resistance …